These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 36304945)

  • 1. Milder symptoms and shorter course in patients with re-positive COVID-19: A cohort of 180 patients from Northeast China.
    Li H; Zhu M; Zhang P; Yan X; Niu J; Wang Z; Cao J
    Front Microbiol; 2022; 13():989879. PubMed ID: 36304945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiological characteristics of 17 imported patients infected with SARS-CoV-2 Omicron variant.
    Liu X; Chen M; Zhou Z; Chen D; Mo J; Liu J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Mar; 47(3):344-351. PubMed ID: 35545327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of patients with SARS-COV-2 PCR re-positivity after recovering from COVID-19.
    Hu CY; Lei Y; Tang YW; Cui WS; Wu PL; Li YF; Zhou Y; Li XY; Cui H; Xiao LS; Zhao ZX
    Epidemiol Infect; 2023 Feb; 151():e34. PubMed ID: 36799012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiological and clinical characteristics of coronavirus disease (COVID-19) cases at a screening clinic during the early outbreak period: a single-centre study.
    Khan M; Khan H; Khan S; Nawaz M
    J Med Microbiol; 2020 Aug; 69(8):1114-1123. PubMed ID: 32783802
    [No Abstract]   [Full Text] [Related]  

  • 5. Analysis of adjunctive serological detection to nucleic acid test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection diagnosis.
    Liu R; Liu X; Yuan L; Han H; Shereen MA; Zhen J; Niu Z; Li D; Liu F; Wu K; Luo Z; Zhu C
    Int Immunopharmacol; 2020 Sep; 86():106746. PubMed ID: 32619956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection and analysis of nucleic acid in various biological samples of COVID-19 patients.
    Wu J; Liu J; Li S; Peng Z; Xiao Z; Wang X; Yan R; Luo J
    Travel Med Infect Dis; 2020; 37():101673. PubMed ID: 32311437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epidemiological and clinical features of children with mild coronavirus disease 2019].
    Tian JD; Xie M; Wen ZC; Xu JM; Wen C
    Zhongguo Dang Dai Er Ke Za Zhi; 2021 May; 23(5):460-465. PubMed ID: 34020734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of clinical characteristics of patients with different vaccines and underlying diseases infected with novel coronavirus Omicron variant].
    Xu H; Wang J; Gao H; Wang Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Jun; 34(6):571-575. PubMed ID: 35924509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic profile of RT-PCR findings from 301 COVID-19 patients in Wuhan, China: A descriptive study.
    Xiao AT; Tong YX; Gao C; Zhu L; Zhang YJ; Zhang S
    J Clin Virol; 2020 Jun; 127():104346. PubMed ID: 32361324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Nucleic Acid and Antibody Detection Results for SARS-CoV-2 Infection.
    Chen J; Niu Z; Li H; Tang D; Zhang P
    Arch Iran Med; 2021 May; 24(5):427-433. PubMed ID: 34196209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Construction and evaluation of a novel diagnosis pathway for 2019-Corona Virus Disease].
    Xiong Z; Fu L; Zhou H; Liu JK; Wang AM; Huang Y; Huang X; Yi B; Wu J; Li CH; Quan J; Li M; Leng YS; Luo WJ; Hu CP; Liao WH
    Zhonghua Yi Xue Za Zhi; 2020 Apr; 100(16):1223-1229. PubMed ID: 32157849
    [No Abstract]   [Full Text] [Related]  

  • 14. Re-positive Cases of Nucleic Acid Tests in Discharged Patients With COVID-19: A Follow-Up Study.
    Qiao XM; Xu XF; Zi H; Liu GX; Li BH; Du X; Tian ZH; Liu XY; Luo LS; Wang X
    Front Med (Lausanne); 2020; 7():349. PubMed ID: 32656223
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical application of combined detection of SARS-CoV-2-specific antibody and nucleic acid.
    Meng QB; Peng JJ; Wei X; Yang JY; Li PC; Qu ZW; Xiong YF; Wu GJ; Hu ZM; Yu JC; Su W
    World J Clin Cases; 2020 Oct; 8(19):4360-4369. PubMed ID: 33083395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Shedding of SARS-CoV-2 Virus in COVID-19 Patients and Neutralizing Antibody Level].
    Ayhancı T; Toptan H; Özer YE; Uzar S; Enül H; Adıay C; Sarac F; Dheir H; Köroğlu M; Hasöksüz M; Altındiş M
    Mikrobiyol Bul; 2022 Jul; 56(3):416-431. PubMed ID: 35960235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between viral load, infection-to-delivery interval and mother-to-child transfer of anti-SARS-CoV-2 antibodies.
    Poon LC; Leung BW; Ma T; Yu FNY; Kong CW; Lo TK; So PL; Leung WC; Shu W; Cheung KW; Moungmaithong S; Wang CC
    Ultrasound Obstet Gynecol; 2021 Jun; 57(6):974-978. PubMed ID: 33798280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What contributes to the re-positive nucleic acid test results for the omicron variant of SARS-CoV-2 in the shelter cabin hospital in Shanghai, China?
    Peng M; Hu M; Peng X; Gong Y; Qian K; Li J; Zhao J; Li X; Huang J; Zhang M; Chai L; Chen L; Zhang D; Peng L
    Heliyon; 2023 May; 9(5):e15679. PubMed ID: 37124338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.